Cargando…

Delivery of gene silencing agents for breast cancer therapy

The discovery of RNA interference has opened the door for the development of a new class of cancer therapeutics. Small inhibitory RNA oligos are being designed to specifically suppress expression of proteins that are traditionally considered nondruggable, and microRNAs are being evaluated to exert b...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Haifa, Mittal, Vivek, Ferrari, Mauro, Chang, Jenny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706796/
https://www.ncbi.nlm.nih.gov/pubmed/23659575
http://dx.doi.org/10.1186/bcr3413